| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 116.62× | 116.62× | 161.99× | 200.47× | 195.04× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 21.77× | 20.71× | 9.57× | 7.47× | 3.76× | ||
| 0.10× | 0.10× | 0.11× | 0.11× | 0.13× | ||
| 0.78× | 0.78× | 1.47× | 1.72× | 1.11× | ||
| 0.63× | 0.63× | 0.91× | 1.43× | 0.75× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 195.04 | 200.47 | 161.99 | 116.62 | 116.62 | |
| Working Capital Turnover | 3.76 | 7.47 | 9.57 | 20.71 | 21.77 | |
| Asset Turnover | 0.13 | 0.11 | 0.11 | 0.10 | 0.10 | |
| Cash Conversion (CFO/Net Income) | 1.11 | 1.72 | 1.47 | 0.78 | 0.78 | |
| CFO/EBITDA | 0.75 | 1.43 | 0.91 | 0.63 | 0.63 |